On March 16, 2026, MaxCyte, Inc. received a notice from the Listing Qualifications staff of The Nasdaq Stock Market LLC indicating that the company's common stock has fallen below the minimum bid price requirement of $1.00 per share for 30 consecutive trading days. This notice does not immediately affect the listing of MaxCyte's common stock on the Nasdaq Global Select Market, and the stock will continue to trade as usual. The company has been granted an initial compliance period of 180 calendar days, expiring on September 14, 2026, to regain compliance with the minimum bid price requirement. To achieve compliance, the closing bid price must meet or exceed $1.00 per share for a minimum of 10 consecutive trading days prior to the deadline. If compliance is not regained by the deadline, MaxCyte may apply for an additional 180-day compliance period by transferring its listing from the Nasdaq Global Select Market to the Nasdaq Capital Market, provided it meets other listing requirements. The company has expressed uncertainty regarding its ability to regain compliance with the minimum bid price requirement, which could lead to potential delisting if not addressed.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.